Search Results - "Sini, Patrizia"

Refine Results
  1. 1

    Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells by Sini, Patrizia, James, Dominic, Chresta, Christine, Guichard, Sylvie

    Published in Autophagy (16-05-2010)
    “…mTOR is a major biological switch, coordinating an adequate response to changes in energy uptake (amino acids, glucose), growth signals (hormones, growth…”
    Get full text
    Journal Article
  2. 2

    The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression by Phadke, Manali S, Sini, Patrizia, Smalley, Keiran S M

    Published in Molecular cancer therapeutics (01-06-2015)
    “…Resistance to BRAF inhibitors is a major clinical problem. Here, we evaluate BI-847325, an ATP-competitive inhibitor of MEK and Aurora kinases, in…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways by Samarzija, Ivana, Sini, Patrizia, Schlange, Thomas, MacDonald, Gwen, Hynes, Nancy E.

    “…Untangling the signaling pathways involved in endothelial cell biology is of central interest for the development of antiangiogenesis based therapies. Here we…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity by Cummings, Jeffrey, Hodgkinson, Cassandra, Odedra, Rajesh, Sini, Patrizia, Heaton, Simon P, Mundt, Kirsten E, Ward, Tim H, Wilkinson, Robert W, Growcott, Jim, Hughes, Andrew, Dive, Caroline

    Published in Molecular cancer therapeutics (01-03-2008)
    “…M30 and M65 are ELISAs that detect different circulating forms of cytokeratin 18. Using the aurora kinase inhibitor AZD1152 and the SW620 human colon cancer…”
    Get full text
    Journal Article
  7. 7

    The Antitumor and Antiangiogenic Activity of Vascular Endothelial Growth Factor Receptor Inhibition Is Potentiated by ErbB1 Blockade by SINI, Patrizia, WYDER, Lorenza, SCHNELL, Christian, O'REILLY, Terence, LITTLEWOOD, Amanda, BRANDT, Ralph, HYNES, Nancy E, WOOD, Jeanette

    Published in Clinical cancer research (15-06-2005)
    “…Purpose: Receptor tyrosine kinases of the ErbB family play important roles in the control of tumor growth. Vascular endothelial growth factor (VEGF) stimulates…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Abstract 703: A novel ATP-competitive MEK/Aurora kinase inhibitor BI-847325 reverses acquired BRAF inhibitor resistance through suppression of Mcl-1 and inhibition of MEK expression by Phadke, Manali S., Sini, Patrizia, Smalley, Keiran

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract BACKGROUND: BRAF/MEK inhibitors have shown promising levels of response in melanomas harboring the BRAF V600E mutation, however responses tend to be…”
    Get full text
    Journal Article
  10. 10

    Heterogeneous Profile of ROR1 Protein Expression across Tumor Types by Raso, Maria Gabriela, Barrientos Toro, Elizve, Evans, Kurt, Rizvi, Yasmeen, Lazcano, Rossana, Akcakanat, Argun, Sini, Patrizia, Trapani, Francesca, Madlener, Eva Johanna, Waldmeier, Lorenz, Lazar, Alexander, Meric-Bernstam, Funda

    Published in Cancers (15-05-2024)
    “…The Wnt receptor ROR1 has generated increased interest as a cancer therapeutic target. Research on several therapeutic approaches involving this receptor is…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation by Di Fiore, Pier Paolo, Scita, Giorgio, Sini, Patrizia, Cannas, Angela, Koleske, Anthony J

    Published in Nature cell biology (01-03-2004)
    “…The non-receptor tyrosine kinase Abl participates in receptor tyrosine kinase (RTK)-induced actin cytoskeleton remodelling, a signalling pathway in which the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Abstract 1919: Pharmacological characterization of BI 847325, a dual inhibitor of MEK and Aurora kinases by Sini, Patrizia, Gürtler, Ulrich, Zahn, Stephan K., Boehmelt, Guido, Garin-Chesa, Pilar, Kraut, Nobert, Rudolph, Dorothea, Solca, Flavio, Tontsch-Grunt, Ulrike, Waizenegger, Irene C., Adolf, Günther R.

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract The RAS-dependent MAP kinase signaling pathway plays an important role in the regulation of cell proliferation and survival. RAS genes are frequently…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Role of decorin on in vitro fibrillogenesis of type I collagen by Sini, P, Denti, A, Tira, M E, Balduini, C

    Published in Glycoconjugate journal (01-11-1997)
    “…Tendon and corneal decorins are differently iduronated dermatan sulphate/proteoglycan (DS/PG) and the biochemical parameter that differentiates type I…”
    Get full text
    Journal Article
  19. 19

    Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen by Tenni, Ruggero, Viola, Manuela, Welser, Franz, Sini, Patrizia, Giudici, Camilla, Rossi, Antonio, Tira, M Enrica

    Published in European journal of biochemistry (01-03-2002)
    “…Decorin is a small leucine-rich chondroitin/dermatan sulfate proteoglycan reported to interact with fibrillar collagens through its protein core and to…”
    Get full text
    Journal Article
  20. 20

    Interaction of decorin with CNBr peptides from collagens I and II by Tenni, Ruggero, Viola, Manuela, Welser, Franz, Sini, Patrizia, Giudici, Camilla, Rossi, Antonio, Tira, M. Enrica

    Published in European journal of biochemistry (01-03-2002)
    “…Decorin is a small leucine‐rich chondroitin/dermatan sulfate proteoglycan reported to interact with fibrillar collagens through its protein core and to…”
    Get full text
    Journal Article